Remdesivir
RxNorm 2284718
Concept Hierarchy & Relationship Mapping
RxNorm Concept Unique Identifier (RxCUI) 2284718 represents a standardized clinical drug concept used for cross-system interoperability. This concept aggregates multiple Atom IDs (AUIs), which are specific naming variations and synonyms used across pharmaceutical databases to ensure accurate medication mapping for: remdesivir.
The following semantic concepts and normalized strings are associated with this clinical entity:
This clinical crossover tool is designed for healthcare professionals, pharmacists, and data analysts to safely compare substitute products and manage medication interoperability.
FNPrescribable
Full form of descriptor (FN):
Product containing remdesivir (medicinal product)
(Atom ID: 12421873)
INPrescribable
Ingredient (IN):
Remdesivir
(Atom ID: 11836722)
PTPrescribable
Designated preferred name (PT):
Remdesivir
(Atom ID: 12421909)
FNPrescribable
Full form of descriptor (FN):
Remdesivir (substance)
(Atom ID: 12421910)
PTPrescribable
Designated preferred name (PT):
Remdesivir-containing product
(Atom ID: 12421914)
Patient Education
Remdesivir Injection
Remdesivir injection is used to treat coronavirus disease 2019 (COVID-19 infection) caused by the SARS-CoV-2 virus in hospitalized adults and children 12 years of age and older who weigh at least 88 pounds (40 kg). Remdesivir is in a class of medications called antivirals. It works by stopping the virus from spreading in the body.
[Learn More]
* Please review the disclaimer below.